Artificial intelligence is revolutionizing the diagnosis and understanding of dementia by transforming magnetic resonance imaging into objective, quantitative data. By leveraging large-scale population studies like the Rotterdam study, researchers can now identify subclinical neurodegenerative markers, such as white matter hyperintensities, years before they manifest as clinical symptoms. Wiro Niessen, a professor of biomedical image analysis and founder of Quantib, emphasizes that the future of medical imaging lies in a "learning healthcare system" that integrates AI to enhance human expertise rather than replace it. Achieving this requires collaborative efforts to build high-quality, multi-center datasets, rigorous validation against independent data, and seamless integration into clinical workflows. These advancements enable clinicians to utilize data from previous patients to provide more accurate diagnoses, prognoses, and treatment selections for future patients.
Sign in to continue reading, translating and more.
Open full episode in Podwise
